Search research articles
Contact Us
Filters
Showing results (1-10 of 37) with videos related to
Page
of 4
Sort By:
Allergy
|
November 10, 2023
Biomarkers of immediate drug hypersensitivity
Cristobalina Mayorga, Adriana Ariza, Rosa Muñoz-Cano, et al.
Allergy
|
September 29, 2020
Advances and novel developments in drug hypersensitivity diagnosis
Adriana Ariza, Cristobalina Mayorga, Gador Bogas, et al.
Allergy
|
April 30, 2019
Expression of the Tim3-galectin-9 axis is altered in drug-induced maculopapular exanthema
Ruben Fernandez-Santamaría, Francisca Palomares, Maria Salas, et al.
Allergy
|
August 1, 2022
Drug hypersensitivity, in vitro tools, biomarkers, and burden with COVID-19 vaccines
Francisca Palomares, Juan L Paris, Marina Labella, et al.
Allergy
|
August 31, 2024
Basophil activation test is a complementary tool in the diagnosis of immediate reactions to platinum salts and taxanes
Gádor Bogas, Adriana Ariza, Paula Vázquez-Revuelta, et al.
Allergy
|
October 24, 2021
The value of the basophil activation test in the evaluation of patients reporting allergic reactions to the BNT162b2 mRNA COVID-19 vaccine
Marina Labella, Jose Antonio Céspedes, Inmaculada Doña, et al.
Allergy
|
November 12, 2025
Allergological Work-Up in Cephalosporin Allergy Diagnosis and Delabelling: The Experience From Two European Allergy Centres
María Salas, Alessandro Ghilarducci, Inmaculada Doña, et al.
Allergy
|
August 31, 2019
Progress in understanding hypersensitivity reactions to nonsteroidal anti-inflammatory drugs
Inmaculada Doña, Natalia Pérez-Sánchez, Ibon Eguiluz-Gracia, et al.
Allergy
|
March 2, 2021
Single-dose prolonged drug provocation test, without previous skin testing, is safe for diagnosing children with mild non-immediate reactions to beta-lactams
Ana Prieto, Candelaria Muñoz, Gádor Bogas, et al.
Allergy
|
May 16, 2025
Direct Single-Dose Drug-Provocation Test Is Safe for Delabelling Penicillin Low-Risk Reactions in Adults
Marina Labella, Julia Rodriguez de Guzmán, Patricia Diez-Echave, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 37) with videos related to
Sort By:
Page
of 4
Allergy
|
November 10, 2023
Biomarkers of immediate drug hypersensitivity
Cristobalina Mayorga, Adriana Ariza, Rosa Muñoz-Cano, et al.
Allergy
|
September 29, 2020
Advances and novel developments in drug hypersensitivity diagnosis
Adriana Ariza, Cristobalina Mayorga, Gador Bogas, et al.
Allergy
|
April 30, 2019
Expression of the Tim3-galectin-9 axis is altered in drug-induced maculopapular exanthema
Ruben Fernandez-Santamaría, Francisca Palomares, Maria Salas, et al.
Allergy
|
August 1, 2022
Drug hypersensitivity, in vitro tools, biomarkers, and burden with COVID-19 vaccines
Francisca Palomares, Juan L Paris, Marina Labella, et al.
Allergy
|
August 31, 2024
Basophil activation test is a complementary tool in the diagnosis of immediate reactions to platinum salts and taxanes
Gádor Bogas, Adriana Ariza, Paula Vázquez-Revuelta, et al.
Allergy
|
October 24, 2021
The value of the basophil activation test in the evaluation of patients reporting allergic reactions to the BNT162b2 mRNA COVID-19 vaccine
Marina Labella, Jose Antonio Céspedes, Inmaculada Doña, et al.
Allergy
|
November 12, 2025
Allergological Work-Up in Cephalosporin Allergy Diagnosis and Delabelling: The Experience From Two European Allergy Centres
María Salas, Alessandro Ghilarducci, Inmaculada Doña, et al.
Allergy
|
August 31, 2019
Progress in understanding hypersensitivity reactions to nonsteroidal anti-inflammatory drugs
Inmaculada Doña, Natalia Pérez-Sánchez, Ibon Eguiluz-Gracia, et al.
Allergy
|
March 2, 2021
Single-dose prolonged drug provocation test, without previous skin testing, is safe for diagnosing children with mild non-immediate reactions to beta-lactams
Ana Prieto, Candelaria Muñoz, Gádor Bogas, et al.
Allergy
|
May 16, 2025
Direct Single-Dose Drug-Provocation Test Is Safe for Delabelling Penicillin Low-Risk Reactions in Adults
Marina Labella, Julia Rodriguez de Guzmán, Patricia Diez-Echave, et al.
Page
of 4